Skip to main content
. 2014 Aug 15;9(8):e104503. doi: 10.1371/journal.pone.0104503

Figure 2. Inactivation of Smad4 in Smad4CKO ureter.

Figure 2

(A-D) Immunostaining of Smad4 in the control (A and C, Tbx18Cre/+;Smad4f/+) and mutant ureters (B and D, Smad4CKO) in the proximal and distal positions at E15.5. Arrowheads indicate urothelium and arrows indicate ureteral mesenchyme and SMCs.